Published in World J Hepatol on August 27, 2014
Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study. Gut (2015) 0.88
Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? Eur Heart J (2016) 0.87
Potential epigenetic mechanism in non-alcoholic Fatty liver disease. Int J Mol Sci (2015) 0.84
MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH. J Clin Med (2015) 0.81
Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. J Clin Med (2016) 0.81
Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field. World J Hepatol (2015) 0.81
Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid β-oxidation. Sci Rep (2016) 0.78
Circulating microRNAs in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol (2015) 0.77
A micro-RNA expression signature for human NAFLD progression. J Gastroenterol (2016) 0.76
Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population. World J Gastroenterol (2016) 0.75
Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health. Int J Mol Sci (2016) 0.75
Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism-The Young Finns Study. Sci Rep (2016) 0.75
Joint Profiling of miRNAs and mRNAs Reveals miRNA Mediated Gene Regulation in the Göttingen Minipig Obesity Model. PLoS One (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Non-coding RNAs in human disease. Nat Rev Genet (2011) 11.40
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest (2005) 9.09
Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology (2010) 4.72
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology (2008) 3.68
Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One (2011) 2.48
Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res (2009) 2.45
Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology (2011) 2.44
MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One (2009) 1.81
Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol (2006) 1.80
Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. J Lipid Res (2009) 1.43
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One (2012) 1.41
Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes. Mol Cell Biochem (2011) 1.32
Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2010) 1.31
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. J Gastroenterol Hepatol (2009) 1.17
Hepatitis C virus infection, microRNA and liver disease progression. World J Hepatol (2013) 1.14
Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease. World J Gastroenterol (2012) 1.13
Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening. J Biomol Screen (2010) 1.05
MicroRNAs and beyond: the heart reveals its treasures. Hypertension (2009) 1.01
MicroRNAs in Vascular Biology. Int J Vasc Med (2012) 0.89
Is nonalcoholic fatty liver disease the hepatic expression of the metabolic syndrome? World J Hepatol (2012) 0.80